| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Apr'15 | Apr'14 | Apr'13 | Apr'12 | Apr'11 |
|---|---|---|---|---|---|---|---|---|
Product Revenue | ||||||||
- | - | - | - | 0 | 25 | 92 | 100 | 322 |
Cost of sales | ||||||||
- | - | - | - | 0 | 129 | 43 | 51 | 219 |
Net product revenue | ||||||||
- | - | - | - | 0 | -104 | 49 | 49 | 103 |
Government grant revenue | ||||||||
- | - | - | - | 49 | 262 | 1,141 | 314 | 0 |
Total net revenue | ||||||||
- | - | - | - | 49 | 158 | 1,190 | 363 | 103 |
Operating expenses | ||||||||
General and administrative | ||||||||
5,084 | 5,653 | 5,678 | 6,245 | 7,170 | 13,773 | 3,676 | 6,091 | 7,682 |
Research and development | ||||||||
3,471 | 1,239 | 3,527 | 13,139 | 6,660 | 2,996 | 2,455 | 2,462 | 2,681 |
Restructuring expense | ||||||||
- | - | - | - | - | - | 220 | 0 | - |
Loss on impairment of long-lived assets | ||||||||
- | - | - | 33,265 | 1,034 | 0 | 27 | 29 | 302 |
Total operating expenses | ||||||||
8,555 | 6,893 | 9,205 | 52,650 | 14,866 | 16,770 | 6,379 | 8,583 | 10,665 |
Net operating loss | ||||||||
-8,555 | -6,893 | -9,205 | -52,650 | -14,816 | -16,611 | -5,189 | -8,220 | 10,562 |
Interest expense | ||||||||
- | - | - | - | 49 | 2,212 | 4,238 | 7,412 | -171 |
Loss on extinguishment of debt | ||||||||
- | - | - | - | - | - | - | 0 | 0 |
Other income | ||||||||
160 | 79 | 366 | 764 | 784 | -718 | 11 | -80 | -285 |
Deemed dividend on preferred stock | ||||||||
0 | 7,330 | 0 | - | - | - | - | - | - |
Income tax benefit | ||||||||
- | - | - | -7,962 | 0 | 0 | - | - | - |
Net loss | ||||||||
-8,394 | -14,144 | -8,839 | -43,923 | -14,081 | -19,541 | -9,415 | -15,712 | 10,448 |
Unrealized loss (gain) on marketable securities | ||||||||
0 | -16 | -2 | -110 | -26 | 0 | 0 | - | - |
Total comprehensive loss | ||||||||
8,394 | 14,127 | 8,837 | 43,813 | 14,055 | 19,541 | 9,415 | - | - |
Net loss | ||||||||
-8,394 | -14,144 | -8,839 | -43,923 | -14,081 | -19,541 | -9,415 | -15,712 | 10,448 |
Preferred stock dividend | ||||||||
- | - | - | - | 0 | 5,803 | 958 | 0 | - |
Net loss attributable to common stockholders | ||||||||
- | - | - | - | 14,081 | 25,345 | 10,373 | 15,712 | - |
Net loss per share, basic and diluted | ||||||||
-1.35 | -9.04 | -6.27 | -31.24 | -0.50 | -2.71 | - | - | - |
Weighted average number of common shares outstanding, basic and diluted | ||||||||
6,195 | 1,564 | 1,410 | 1,405 | 28,077 | 9,362 | - | - | - |
Net loss per share, basic | ||||||||
- | - | - | - | - | - | -6.29 | -12.12 | -0.45 |
Weighted average number of common shares outstanding, basic | ||||||||
- | - | - | - | - | - | 1,650 | 1,296 | 23,346 |
Net loss per share, diluted | ||||||||
- | - | - | - | - | - | -6.68 | -14.07 | -0.45 |
Weighted average number of common shares outstanding, diluted | ||||||||
- | - | - | - | - | - | 1,759 | 1,387 | 23,346 |